Replimune Group Inc (REPL)
$17.61 +1.27% Close Oct 30, 2026 Live
Replimune Group stock today
Replimune Group closed at $17.61 on October 30, 2026, up 1.27% on the day. Over the past year it returned +71.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.66 billion.
$5.00$10.00$15.00
NovJan 2026MarMayJulSep
| Period | REPL | S&P 500 (SPY) |
|---|---|---|
| 1 month | +33.0% | -0.9% |
| 3 months | +225.5% | +2.1% |
| Year to date | +81.2% | +11.7% |
| 1 year | +71.8% | +12.4% |
| 3 years | +23.7% | +88.5% |
| 5 years | -40.3% | +76.0% |
Key statistics
- Market value
- $1.66B
- 52-week range
- $1.70 to $17.61
About Replimune Group
Biopharmaceutical company developing immunotherapy cancer treatments.
Sector: Health Care
More on Replimune Group
- Returns: what $1,000 became$1,000 five years ago is $596.75 today
No forecast, no recommendation. This page describes Replimune Group Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.